APTO Insider Trading
Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 1.33%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
Aptose Biosciences Share Price & Price History
Current Price: $0.00
Price Change: +0.30 (1.20%)
As of 04/1/2025 05:00 PM ET
Aptose Biosciences Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 11/25/2024 | William G. Rice | CEO | Buy | 3,333 | $6.00 | $19,998.00 | 20,441 |  |
| 9/22/2023 | Bernd R Seizinger | Director | Buy | 566 | $94.20 | $53,317.20 | 566 | |
Aptose Biosciences Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 2/17/2025 | Bleichroeder LP | 2,500,000 | $0.56M | 0.1% | N/A | 4.154% |  |
| 2/3/2025 | Sigma Planning Corp | 703,384 | $0.16M | 0.0% | +75.1% | 1.169% | |
| 11/4/2024 | Sigma Planning Corp | 401,750 | $0.17M | 0.0% | +71.3% | 2.220% | |
| 8/15/2024 | Armistice Capital LLC | 1,713,000 | $1.30M | 0.0% | N/A | 9.459% | |
| 2/8/2024 | Texas Capital Bank Wealth Management Services Inc | 12,448 | $32K | 0.0% | N/A | 0.157% | |
| 2/1/2024 | Sigma Planning Corp | 75,477 | $0.19M | 0.0% | -48.2% | 0.951% | |
| 11/15/2023 | Annandale Capital LLC | 74,666 | $0.21M | 0.1% | +40.0% | 0.990% | |
| 11/6/2023 | Sigma Planning Corp | 145,786 | $0.41M | 0.0% | N/A | 1.934% | |
| 8/10/2023 | Carlson Capital L P | 106,666 | $0.50M | 0.0% | -93.5% | 0.114% | |
| 7/28/2023 | Voss Capital LLC | 14,634 | $68K | 0.0% | -97.3% | 0.016% | |
| 5/8/2023 | Sigma Planning Corp | 1,444,550 | $0.93M | 0.0% | +34.9% | 1.562% | |
| 2/15/2023 | Nantahala Capital Management LLC | 6,052,867 | $3.51M | 0.2% | -12.1% | 6.553% | |
| 2/13/2023 | Callan Capital LLC | 156,986 | $91K | 0.0% | N/A | 0.170% | |
| 2/13/2023 | Voss Capital LLC | 550,000 | $0.32M | 0.1% | -8.3% | 0.595% | |
| 2/7/2023 | Formidable Asset Management LLC | 90,000 | $52K | 0.0% | N/A | 0.097% | |
| 1/24/2023 | Sigma Planning Corp | 1,070,504 | $0.62M | 0.0% | +19.0% | 1.160% | |
| 11/15/2022 | Carlson Capital L P | 2,010,000 | $1.20M | 0.1% | +5.4% | 2.178% | |
| 11/14/2022 | Annandale Capital LLC | 710,000 | $0.42M | 0.2% | +81.6% | 0.769% | |
| 11/10/2022 | Sigma Planning Corp | 899,554 | $0.54M | 0.0% | +6.8% | 0.975% | |
| 11/10/2022 | Nantahala Capital Management LLC | 6,888,822 | $4.10M | 0.3% | -4.8% | 7.464% | |
| 11/9/2022 | Toronto Dominion Bank | 43,851 | $26K | 0.0% | +80.4% | 0.048% | |
| 11/2/2022 | Voss Capital LLC | 600,000 | $0.36M | 0.1% | -14.3% | 0.650% | |
| 10/7/2022 | Sanders Morris Harris LLC | 657,364 | $0.40M | 0.1% | -35.8% | 0.712% | |
| 8/15/2022 | Nantahala Capital Management LLC | 7,232,676 | $5.37M | 0.3% | -1.2% | 7.837% | |
| 8/13/2022 | Voss Capital LLC | 700,010 | $0.52M | 0.2% | +27.3% | 0.759% | |
| 8/11/2022 | Sigma Planning Corp | 842,174 | $0.63M | 0.0% | +6.4% | 0.913% | |
| 7/11/2022 | Sanders Morris Harris LLC | 1,024,215 | $0.81M | 0.2% | -56.3% | 1.110% | |
| 5/12/2022 | Annandale Capital LLC | 200,000 | $0.27M | 0.1% | N/A | 0.217% | |
| 5/12/2022 | Cetera Advisors LLC | 60,895 | $83K | 0.0% | +87.7% | 0.066% | |
| 5/9/2022 | Toronto Dominion Bank | 50,186 | $68K | 0.0% | +76.6% | 0.054% | |
| 5/4/2022 | Formidable Asset Management LLC | 90,000 | $0.12M | 0.0% | N/A | 0.098% | |
| 4/22/2022 | Gleason Group Inc. | 18,250 | $25K | 0.0% | N/A | 0.020% | |
| 4/20/2022 | Sigma Planning Corp | 791,274 | $1.08M | 0.0% | +39.5% | 0.858% | |
| 4/11/2022 | Sanders Morris Harris LLC | 2,342,694 | $3.19M | 0.6% | +19.4% | 2.540% | |
| 2/15/2022 | 683 Capital Management LLC | 2,019,770 | $2.73M | 0.1% | -35.1% | 2.190% | |
| 2/14/2022 | Bayesian Capital Management LP | 37,800 | $51K | 0.0% | N/A | 0.041% | |
| 2/14/2022 | Rockefeller Capital Management L.P. | 21,809 | $29K | 0.0% | +1,334.8% | 0.024% | |
| 2/10/2022 | WealthShield Partners LLC | 104,920 | $0.14M | 0.0% | +40.8% | 0.114% | |
| 2/10/2022 | P.A.W. Capital Corp | 565,000 | $0.76M | 0.7% | -24.7% | 0.613% | |
| 2/9/2022 | BNP Paribas Arbitrage SA | 686,058 | $0.93M | 0.0% | +101.4% | 0.744% | |
| 2/7/2022 | Texas Capital Bank Wealth Management Services Inc. | 25,000 | $34K | 0.0% | N/A | 0.027% | |
| 2/4/2022 | Toronto Dominion Bank | 28,410 | $38K | 0.0% | +1,070.1% | 0.031% | |
| 2/2/2022 | Sanders Morris Harris LLC | 1,961,594 | $2.92M | 0.5% | +42.8% | 2.127% | |
| 2/2/2022 | Sigma Planning Corp | 567,314 | $0.77M | 0.0% | +10.7% | 0.615% | |
| 11/24/2021 | Patriot Financial Group Insurance Agency LLC | 54,529 | $0.12M | 0.0% | -66.2% | 0.061% | |
| 11/16/2021 | Opaleye Management Inc. | 549,000 | $1.20M | 0.2% | -44.0% | 0.617% | |
| 11/16/2021 | Voss Capital LLC | 67,600 | $0.15M | 0.1% | -83.9% | 0.076% | |
| 11/16/2021 | Squarepoint Ops LLC | 15,483 | $34K | 0.0% | N/A | 0.017% | |
| 11/16/2021 | Two Sigma Investments LP | 218,633 | $0.48M | 0.0% | N/A | 0.246% | |
| 11/15/2021 | Man Group plc | 260,836 | $0.57M | 0.0% | +77.0% | 0.293% | |
| 11/15/2021 | 683 Capital Management LLC | 3,112,737 | $6.79M | 0.3% | +42.1% | 3.499% | |
| 11/12/2021 | Renaissance Technologies LLC | 723,005 | $1.58M | 0.0% | N/A | 0.813% | |
| 11/12/2021 | Carlson Capital L P | 720,408 | $1.57M | 0.1% | +41.3% | 0.810% | |
| 11/12/2021 | Gagnon Securities LLC | 59,380 | $0.13M | 0.0% | -45.8% | 0.067% | |
| 11/12/2021 | Jump Financial LLC | 105,202 | $0.23M | 0.0% | +11.3% | 0.118% | |
| 11/12/2021 | Prosight Management LP | 70,563 | $0.15M | 0.1% | -46.9% | 0.079% | |
| 11/12/2021 | WealthShield Partners LLC | 74,512 | $0.16M | 0.0% | +83.0% | 0.084% | |
| 11/10/2021 | Goldman Sachs Group Inc. | 751,802 | $1.64M | 0.0% | +12.5% | 0.845% | |
| 11/2/2021 | Raymond James & Associates | 20,150 | $44K | 0.0% | -27.1% | 0.023% | |
| 11/2/2021 | Benjamin F. Edwards & Company Inc. | 20,000 | $44K | 0.0% | +150.0% | 0.022% | |
| 10/28/2021 | Sigma Planning Corp | 512,519 | $1.12M | 0.0% | +34.9% | 0.576% | |
| 10/25/2021 | P.A.W. Capital Corp | 750,000 | $1.64M | 1.5% | +7.1% | 0.843% | |
| 8/17/2021 | Millennium Management LLC | 315,293 | $1.05M | 0.0% | -13.7% | 0.354% | |
Data available starting January 2016
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies. The company has an agreement with CrystalGenomics, Inc. to research, develop, and commercialize CG026806, a non-covalent small molecule therapeutic agent, which is in preclinical stage for the treatment of acute myeloid leukemia and chronic lymphocytic leukemia/mantle cell lymphoma. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was founded in 1986 and is headquartered in Mississauga, Canada.
Read More on Aptose Biosciences
Today's Range
Now: N/A
52 Week Range
Now: N/A
Volume
650,294 shs
Average Volume
227,964 shs
Market Capitalization
$3.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.04
Who are the company insiders with the largest holdings of Aptose Biosciences?
